In this episode, we’ll be exploring the work of Dr. Rashmi Kusurkar, a leading scholar in health professions education whose research centers on the question: how do we develop “students for life”? Her work exists at the intersection of motivation theory, equity, and professional identity, spanning borders, disciplines, and cultures — from advancing Self-Determination Theory in education to addressing access, diversity, and inclusion in healthcare training. Learn more about Dr. Thirusha Naidu...

Darshan explores a critical question for life sciences companies: is your medical affairs team truly independent from commercial—or are you just pretending? In this episode of KLF Deep Dive, Darshan highlights why organizational charts alone are not enough to satisfy regulators. He explains that regulators focus on conduct, process, and intent, not PowerPoint slides. Using the 2013 GlaxoSmithKline settlement as a cautionary example, he demonstrates how blurred lines between medical and commer...

Dr. Don and Professor Ben talk about the risks from using watered down hand soap. Dr. Don - risky ☣️ Professor Ben - risky ☣️ Influence of Soap Characteristics and Food Service Facility Type on the Degree of Bacterial Contamination of Open, Refillable Bulk Soaps - ScienceDirect

What if the answer to battling antibiotic-resistant infections isn’t a new antibiotic, but harnessing viruses that have been quietly dominating bacterial populations? Bacteriophages, viruses that target and kill bacteria, have been saving lives for a century, but their true potential is only now being unlocked by modern machine learning. The race isn’t just about discovering effective phages; it’s about deploying the right therapy, personalized to the patient, before time runs out. On this ep...

On DNA Today, we spend a lot of time talking about genetic testing in the U.S., but what does this look like in other parts of the world? Since it’s Breast Cancer Awareness Month, we’re shifting our focus to Italy to explore how breast cancer genetic testing is being implemented there.We’re joined by two expert guests: Dr. Beatrice Salvatori, is a Scientist and Project Manager at Negedia, where she leads oncology-related projects and develops new research initiatives. With a PhD in Genetics and

Tales from the Farm recounts the Flying Goat Farm February 2025 Canadian Pasteurizer Expedition. (There are a number of short skips in the audio in this episode due to equipment error and bad SD card formatting or something- apologies for missing a couple of details, but the epic journey is pretty well documented and we think you'll get the gist.) goatdoccara@gmail.comSupport this show http://supporter.acast.com/goatdoc. Hosted on Acast. See acast.com/privacy for more information.

Parasites have roamed the Earth for a long time. They were here before the dinosaurs: The oldest fossils are more than 500 million years old. Today on the show, Regina G. Barber speaks with paleontologists Karma Nanglu and Danielle de Carle about a mysterious fossil called the “Riddler,” and the oldest-ever leech fossil. They share stories of the enduring power of parasitism through the ages and why the clues to prehistoric mysteries may be tucked in a basement.Interested in more science behind rare

In our last two episodes, we spoke with Dr. Carol Gilligan and Dr. Niobe Way, whose forty years of research show how society’s gender expectations of being “good girls” and “strong boys” are creating a crisis of connection that’s costing all of us. So what do we do when we recognize so many of us are trapped by society’s gender expectations that were never ours to begin with?[0:02] Evie and Chelle open the episode and share the gender expectations they’re shaking off.[1:34] Chelle recaps Dr. Carol

One of the challenges we face in Australia is getting more homegrown medtech products purchased and used by local hospitals and health services. MTPConnect’s Pathway to Market – Medtech Capability Uplift Program has been supporting ten market-ready Victorian medtech manufacturers to position themselves competitively for local health procurement opportunities. The recent Australian Medtech Manufacturing Alliance (AMMA) Medtech Showcase profiled Victorian-made products and innovatio...

This episode covers growth charts.Written notes can be found at https://zerotofinals.com/paediatrics/development/growthcharts/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

In the news podcast, a new retinal implant - just two millimetres wide - that is helping restore sight to blind people; a 'pristine' star that gives us a glimpse of the workings of the early Universe; and we'll be finding out how wild rooks can master human commands. Like this podcast? Please help us by supporting the Naked Scientists

It took Sophie Kornowski under four years as CEO of Boston Pharma to bring it from a pipeline full of in-licensed assets to an acquisition by GSK for about $2 billion in total deal value for a single MASH program. Though her first gig as a biotech CEO, Kornowski’s success was built on her years of experience as head of partnering at Roche. She discussed that pivot and the value of rolling your sleeves up on the latest episode of The BioCentury Show. View full story: https://www.biocentury.com...

Caroline and Harry dive into Sara’s challenge—a top-performing account manager who joins a new pharma company, only to be met with a rigid culture of scripted, “tell-sell” conversations. Despite mounting pressure to fit in, this approach feels increasingly out of step with today’s healthcare realities. The data backs this up: analysis of 2.5 million sales calls by Harvard Business Review and findings from a Cochrane Review reveal a 5–6% increase in prescribing when conversations are tailored to

In this twice-damned duology from Stuff to Blow Your Mind, Robert and Joe discuss creatures of the natural world that collect bones...See omnystudio.com/listener for privacy information.

Just back from IDWeek 2025 in Atlanta, Luis shares the sessions and posters that defined this year’s meeting — from next-generation sequencing and diagnostic stewardship to AI in the microbiology lab and new antimicrobials on the horizon. Tune in for insights on: NGS test utilization and stewardship New β-lactamase inhibitors like nacubactam  AI’s growing role in clinical microbiology Tedizolid and the importance of optimizing existing agents 🎧 Whether you were in Atlanta or following

China is setting a new bar for the speed of clinical development and redefining the time it takes an asset to get to the clinic. On a special edition of the BioCentury This Week podcast recorded on stage at the 12th BioCentury BayHelix China Healthcare Summit in Shanghai, BioCentury's Simone Fishburn argued that China’s emerging new standard for swift entry to the clinic could upend the bottleneck of translational development and usher in a new paradigm that could have a “massive impact globa...

Erin Silva, Ph.D. https://cias.wisc.edu/directory/17158/FoA 280: Organic Farming Myths and Realities With Erin SilvaI wanted to invite Erin Silva back on the show to hear about her continued work with farmers that are going down the path of organic AND regenerative. On the surface, those two farming approaches are easy to get behind: let’s try to reduce our dependence on synthetic chemistry and let’s try to build soil health over time while still farming intensively and profitably. But in practice,

This week’s tHEORetically Speaking News Roundup covers Evotec and Bristol Myers Squibb’s progress in developing next-generation therapies for neurodegenerative diseases, the FDA’s game-changing move to streamline biosimilar approvals and lower drug costs, and Novo Nordisk’s bold $6.5B counteroffer to outbid Pfizer for Metsera in the obesity treatment race. Tune in for this concise recap of the top stories shaping HEOR, RWE, and Market Access this week.

Joel White, Owner of Marketcap Consulting, joins another episode to discuss the evolving role of Clinical Research Organizations (CROs). He shares the characteristics of a great CRO, how technology and decentralization are shaping the industry, and the strategic balance between speed, quality, and cost in clinical trials. Whether you're a sponsor, CRO professional, or simply curious about the clinical trial landscape, this episode offers practical wisdom and forward-looking perspectives on drug